Losing weight isn’t just about willpower. Discover what research says about losing weight, why one-size-fits-all diets don’t work, and how to find what works for you.

It’s taken more than a decade of research and campaigning but now polycystic ovary syndrome – a chronic condition that ...

“Ozempic personality” is a new term making the rounds on social media, describing a subtle emotional shift that some people say they’ve noticed as a side effect of GLP-1 weight loss medications. These ...

Wegovy® showed an average 22.6% weight loss for premenopausal women with obesity, with more than 4 in 10 (41.4%) achieving 25 ...

In a post-hoc analysis of the STEP UP trial, premenopausal women with obesity lost an average of 22.6% of body weight on once ...

Novo Nordisk today announced data demonstrating that Wegovy® (semaglutide 2.4 mg and 7.2 mg) delivers substantial and ...

Side effects like nausea, vomiting, diarrhea and constipation are common soon after starting GLP-1s or increasing the drug’s dosage. A nutrient-dense diet and regular exercise a ...

Which works best: Network meta-analyses show lurasidone, quetiapine, olanzapine, and cariprazine outperform placebo for bipolar depression, with lurasidone showing strong response rates. Side effect ...

Andrew Whitehair, a CPA at Baker Tilly, serves a national clientele of tech bros with mega capital gains. His advice: Don't get too technical with your tax maneuvers. What to do if much of your wealth ...

Discover how hormones, metabolism, and lifestyle factors contribute to weight gain in women over 50. Also, learn tips for ...

Antidepressant therapies modulate monoaminergic neurotransmission, principally via serotonin, noradrenaline and dopamine pathways. Classes include selective serotonin reuptake inhibitors (SSRIs), ...